Eliem Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €0.00 +NaN% -€128.73M +47.3% N/A N/A N/A
    (estimated) €0.00 +NaN% -€87.37M +35.7% N/A N/A N/A
    (estimated) N/A -€64.39M +40.4% N/A N/A N/A
    (estimated) N/A -€45.85M +7.0% N/A N/A N/A
    (estimated) N/A -€42.86M -32.2% N/A N/A N/A
    €0.00 +NaN% -€63.26M +110.4% N/A -€13.32M -24.5% N/A
    €0.00 +NaN% -€30.07M -22.6% N/A -€17.63M -44.9% N/A
    €0.00 +NaN% -€38.83M -4.5% N/A -€31.99M +3.6% N/A
    €0.00 +NaN% -€40.65M +312.5% N/A -€30.88M +155.9% N/A
    €0.00 +NaN% -€9.85M +203.1% N/A -€12.07M +181.5% N/A
    €0.00 -€3.25M N/A -€4.29M N/A

    Notifications